Bankruptcy settlement would give Purdue Pharma a free pass

Those responsible for the scourge of opioid addiction that has ravaged communities in Washington and across the country must be held accountable.

Anyone who knowingly contributed to this irresponsible distribution should suffer the consequences, not get a free pass.

But that’s exactly what a proposed bankruptcy settlement would offer OxyContin maker Purdue Pharma, its wealthy owners and associates. Those seeking compensation and remedies for death and injury have until July 14 to decide whether to vote for the plan, approved by a federal bankruptcy judge last week. They should decline.

OxyContin, 80 mg tablets, in a 2013 file image (Liz O. Baylen / Los Angeles Times / TNS)

Under the 499-page proposal, the Sackler family would relinquish control of the business and pay $ 4.5 billion to fund opioid treatment and mitigation over nearly a decade. But money comes at too high a price: blanket immunity for dozens of the Sackler family, including business owners and directors, and hundreds of businesses, trusts, consultants and others. associates, for the damage caused when communities were inundated with their addictive drugs. .

Comments are closed.